Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,370.00
+20.00 (0.31%)
At close: Mar 6, 2026
-8.20%
Market Cap 53.93B
Revenue (ttm) 76.74B
Net Income (ttm) 2.12B
Shares Out 8.83M
EPS (ttm) 222.54
PE Ratio 27.46
Forward PE n/a
Dividend 95.47 (1.50%)
Ex-Dividend Date Dec 29, 2025
Volume 41,100
Average Volume 91,435
Open 6,310.00
Previous Close 6,350.00
Day's Range 6,150.00 - 6,400.00
52-Week Range 5,800.00 - 9,226.11
Beta 0.84
RSI 49.81
Earnings Date Mar 19, 2026

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.